Defining the role of the Bcl-2 family proteins in Huntington's disease

Cell Death and Disease

Volumn 4, Issue 8, 2013, Pages

  Sassone, J ^a   Maraschi, A ^a   Sassone, F ^a   Silani, V ^a,b   Ciammola, A ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bcl 2 family proteins; Huntington's disease models; Mutated huntingtin

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PUMA PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; ENDOPLASMIC RETICULUM; HUMAN; HUNTINGTON CHOREA; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DEATH; CELL SURVIVAL; HUMANS; HUNTINGTON DISEASE; MITOCHONDRIA; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84882664898     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.300     Document Type: Article

References (92)

1. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006; 443: 658-662 (Pubitemid 44564703)
2. Sheridan C, Delivani P, Cullen SP, Martin SJ. Bax-or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol Cell 2008; 31: 570-585
3. Berman SB, Chen YB, Qi B, McCaffery JM, Rucker EB, Goebbels S et al. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 2009; 184: 707-719
4. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003; 424: 952-956 (Pubitemid 37051687)
5. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 2000; 9: 2799-2809
6. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506 (Pubitemid 26374323)
7. Yamamoto A, Lucas JJ, Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000; 101: 57-66
8. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-Terminal fragment of huntingtin. Hum Mol Genet 1999; 8: 397-407 (Pubitemid 29097327)
9. Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 2003; 12: 1555-1567 (Pubitemid 36857303)
10. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993; 73: 295-307 (Pubitemid 23123308)
11. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608 (Pubitemid 23259741)
12. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163 (Pubitemid 46209992)
13. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994; 120: 301-311
14. Gonzá lez-García M, García I, Ding L, ÓShea S, Boise LH, Thompson CB et al. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 1995; 92: 4304-4308
15. Krajewska M, Mai JK, Zapata JM, Ashwell KW, Schendel SL, Reed JC et al. Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system. Cell Death Differ 2002; 9: 145-157 (Pubitemid 34144774)
16. Majumder P, Raychaudhuri S, Chattopadhyay B, Bhattacharyya NP. Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cell Mol Neurobiol 2007; 27: 1127-1145 (Pubitemid 351170078)
17. Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ et al. Nuclear translocation of AMPK-Alpha1 potentiates striatal neurodegeneration in Huntington's disease. J Cell Biol 2011; 194: 209-227
18. Ruiz C, Casarejos MJ, Rubio I, Gines S, Puigdellivol M, Alberch J et al. The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins. Brain Res 2012; 1459: 100-112
19. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C et al. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991; 51: 6529-6538
20. Placzek WJ, Wei J, Kitada S, Zhai D, Reed JC, Pellecchia M. A survey of the anti-Apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis 2010; 1: E40
21. Zhang Y, Ona VO, Li M, Drozda M, Dubois-Dauphin M, Przedborski S et al. Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease. J Neurochem 2003; 87: 1184-1192 (Pubitemid 37485074)
22. García-Martínez JM, Pérez-Navarro E, Xifró X, Canals JM, Díaz-Hernández M, Trioulier Y et al. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease. J Neurosci Res 2007; 85: 2756-2769 (Pubitemid 47344575)
23. Teles AV, Rosenstock TR, Okuno CS, Lopes GS, Bertoncini CR, Smaili SS. Increase in bax expression and apoptosis are associated in Huntington's disease progression. Neurosci Lett 2008; 438: 59-63
24. Chiang MC, Chen CM, Lee MR, Chen HW, Chen HM, Wu YS et al. Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-Activated receptor gamma. Hum Mol Genet 2010; 19: 4043-4058
25. Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B et al. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 2008; 30: 312-322
26. Vis JC, Schipper E, de Boer-van Huizen RT, Verbeek MM, de Waal RM, Wesseling P et al. Expression pattern of apoptosis-related markers in Huntington's disease. Acta Neuropathol 2005; 109: 321-328 (Pubitemid 41166602)
27. Sanchez Mejia RO, Friedlander RM. Caspases in Huntington's disease. Neuroscientist 2001; 7: 480-489 (Pubitemid 33086416)
28. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966-1968 (Pubitemid 28013242)
29. Almeida S, Sarmento-Ribeiro AB, Januá rio C, Rego AC, Oliveira CR. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. Biochem Biophys Res Commun 2008; 374: 599-603
30. Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. J Neurochem 2001; 78: 694-703 (Pubitemid 32777971)
31. Khoshnan A, Ko J, Tescu S, Brundin P, Patterson PH. IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. PLoS One 2009; 4: E5768
32. Happo L, Strasser A, Cory S. BH3-only proteins in apoptosis at a glance. J Cell Sci 2012; 125: 1081-1087
33. Danial NN, Walensky LD, Zhang CY, Choi CS, Fisher JK, Molina AJ et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med 2008; 14: 144-153 (Pubitemid 351214557)
34. Giménez-Cassina A, Martínez-François JR, Fisher JK, Szlyk B, Polak K, Wiwczar J et al. BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 2012; 74: 719-730
35. Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C et al. Wild-Type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 2000; 20: 3705-3713 (Pubitemid 30266233)
36. Danial NN. BAD: Undertaker by night, candyman by day. Oncogene 2008; 27(Suppl 1): S53-S70
37. Ley R, Hadfield K, Howes E, Cook SJ. Identification of a DEF-Type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL. J Biol Chem 2005; 280: 17657-17663 (Pubitemid 41389001)
38. ÓReilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML et al. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 2000; 157: 449-461 (Pubitemid 30626908)
39. Shibata M, Hattori H, Sasaki T, Gotoh J, Hamada J, Fukuuchi Y. Temporal profiles of the subcellular localization of Bim, a BH3-only protein, during middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2002; 22: 810-820 (Pubitemid 34747598)
40. Leon R, Bhagavatula N, Ulukpo O, McCollum M, Wei J. BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin. Eur J Neurosci 2010; 31: 1915-1925
41. King MA, Goemans CG, Hafiz F, Prehn JH, Wyttenbach A, Tolkovsky AM. Cytoplasmic inclusions of Htt exon1 containing an expanded polyglutamine tract suppress execution of apoptosis in sympathetic neurons. J Neurosci 2008; 28: 14401-14415
42. Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurol Res 2009; 31: 77-83
43. Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellecchia M et al. Apoptosisinducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25: 10262-10272 (Pubitemid 41636223)
44. Engel T, Plesnila N, Prehn JH, Henshall DC. In vivo contributions of BH3-only proteins to neuronal death following seizures, ischemia, and traumatic brain injury. J Cereb Blood Flow Metab 2011; 31: 1196-1210
45. Jhamandas JH, Mactavish DJ. b-Amyloid protein (Ab) and human amylin regulation of apoptotic genes occurs through the amylin receptor. Apoptosis 2012; 17: 37-47
46. Yin XM. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 2006; 369: 7-19
47. Chinnadurai G, Vijayalingam S, Gibson SB. BNIP3 subfamily BH3-only proteins: Mitochondrial stress sensors in normal and pathological functions. Oncogene 2008; 27(Suppl 1): S114-S127
48. Burton TR, Gibson SB. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ 2009; 16: 515-523
49. Zhang J, Ney PA. Mechanisms and biology of B-cell leukemia/lymphoma 2/adenovirus E1B interacting protein 3 and Nip-like protein X. Antioxid Redox Signal 2011; 14: 1959-1969
50. Kubli DA, Ycaza JE, Gustafsson AB. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 2007; 405: 407-415 (Pubitemid 47172037)
51. Landes T, Emorine LJ, Courilleau D, Rojo M, Belenguer P, Arnauné-Pelloquin L. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep 2010; 11: 459-465
52. Quinsay MN, Lee Y, Rikka S, Sayen MR, Molkentin JD, Gottlieb RA et al. Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. J Mol Cell Cardiol 2010; 48: 1146-1156
53. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454-5468 (Pubitemid 30482883)
54. Cho B, Choi SY, Park OH, Sun W, Geum D. Differential expression of BNIP family members of BH3-only proteins during the development and after axotomy in the rat. Mol Cells 2012; 33: 605-610
55. Sassone J, Colciago C, Marchi P, Ascardi C, Alberti L, Di Pardo A et al. Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3). Cell Death Dis 2010; 1: E7
56. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 2002; 99: 12825-12830
57. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007; 14: 146-157 (Pubitemid 44911902)
58. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7: 673-682 (Pubitemid 32706358)
59. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7: 683-694 (Pubitemid 32706359)
60. Engel T, Murphy BM, Hatazaki S, Jimenez-Mateos EM, Concannon CG, Woods I et al. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J 2010; 24: 853-861
61. Niizuma K, Endo H, Nito C, Myer DJ, Chan PH. Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke 2009; 40: 618-625
62. 3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 2003; 162: 587-597 (Pubitemid 37022937)
63. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730 (Pubitemid 32385543)
64. Hara A, Hirose Y, Wang A, Yoshimi N, Tanaka T, Mori H. Localization of Bax and Bcl-2 proteins, regulators of programmed cell death, in the human central nervous system. Virchows Arch 1996; 429: 249-253 (Pubitemid 26402668)
65. MacGibbon GA, Lawlor PA, Sirimanne ES, Walton MR, Connor B, Young D et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res 1997; 750: 223-234 (Pubitemid 27116267)
66. Obonai T, Mizuguchi M, Takashima S. Developmental and aging changes of Bak expression in the human brain. Brain Res 1998; 783: 167-170 (Pubitemid 28131436)
67. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 2005; 47: 29-41 (Pubitemid 40922848)
68. Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A. Huntington's disease: The current state of research with peripheral tissues. Exp Neurol 2009; 219: 385-397
69. Puthalakath H, Huang DC, ÓReilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 287-296 (Pubitemid 29290669)
70. Li Z, Zhang J, Liu Z, Woo CW, Thiele CJ. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ 2007; 14: 318-326 (Pubitemid 46092234)
71. Almeida S, Laço M, Cunha-Oliveira T, Oliveira CR, Rego AC. BDNF regulates BIM expression levels in 3-nitropropionic acid-Treated cortical neurons. Neurobiol Dis 2009; 35: 448-456
72. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001; 293: 493-498 (Pubitemid 32679077)
73. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003; 35: 76-83 (Pubitemid 37048599)
74. Puthalakath H, ÓReilly LA, Gunn P, Lee L, Kelly PN, Huntington ND et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007; 129: 1337-1349 (Pubitemid 46962086)
75. Duennwald ML, Lindquist S. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 2008; 22: 3308-3319
76. Culmsee C, Plesnila N. Targeting Bid to prevent programmed cell death in neurons. Biochem Soc Trans 2006; 34: 1334-1340 (Pubitemid 46769050)
77. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000; 20: 929-935 (Pubitemid 30044230)
78. Sánchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 1999; 22: 623-633 (Pubitemid 29159860)
79. Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 2002; 4: 95-105 (Pubitemid 34141474)
80. Gafni J, Ellerby LM. Calpain activation in Huntington's disease. J Neurosci 2002; 22: 4842-4849 (Pubitemid 37465599)
81. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 2009; 16: 939-946
82. Frazier DP, Wilson A, Graham RM, Thompson JW, Bishopric NH, Webster KA. Acidosis regulates the stability, hydrophobicity, and activity of the BH3-only protein Bnip3. Antioxid Redox Signal 2006; 8: 1625-1634 (Pubitemid 44726337)
83. Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ et al. A unique pathway of cardiac myocyte death caused by hypoxia-Acidosis. J Exp Biol 2004; 207: 3189-3200 (Pubitemid 39275293)
84. Graham RM, Thompson JW, Wei J, Bishopric NH, Webster KA. Regulation of Bnip3 death pathways by calcium, phosphorylation, and hypoxia-reoxygenation. Antioxid Redox Signal 2007; 9: 1309-1315 (Pubitemid 47255010)
85. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuro Report 1995; 6: 1053-1057
86. Thomas LB, Gates DJ, Richfield EK, ÓBrien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995; 133: 265-272
87. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995; 15: 3775-3787
88. Wang H, Lim PJ, Karbowski M, Monteiro MJ. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 2009; 18: 737-752
89. Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol Med 2010; 2: 490-503
90. Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 2011; 17: 377-382
91. Kale J, Liu Q, Leber B, Andrews DW. Shedding light on apoptosis at subcellular membranes. Cell 2012; 151: 1179-1184
92. Davids MS, Letai A. Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol 2012; 30: 3127-3135